These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Glycyrrhizin induces apoptosis in prostate cancer cell lines DU-145 and LNCaP. Thirugnanam S; Xu L; Ramaswamy K; Gnanasekar M Oncol Rep; 2008 Dec; 20(6):1387-92. PubMed ID: 19020719 [TBL] [Abstract][Full Text] [Related]
23. Radiosensitization of hormone-refractory prostate cancer cells by gossypol treatment. Akagunduz O; Karaca B; Atmaca H; Uzunoglu S; Karabulut B; Sanli UA; Haydaroglu A; Uslu R J BUON; 2010; 15(4):763-7. PubMed ID: 21229643 [TBL] [Abstract][Full Text] [Related]
24. An orally active Amazonian plant extract (BIRM) inhibits prostate cancer growth and metastasis. Dandekar DS; Lokeshwar VB; Cevallos-Arellano E; Soloway MS; Lokeshwar BL Cancer Chemother Pharmacol; 2003 Jul; 52(1):59-66. PubMed ID: 12734674 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089. Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302 [TBL] [Abstract][Full Text] [Related]
26. The effects of omega-3 and omega-6 fatty acids on in vitro prostate cancer growth. Pandalai PK; Pilat MJ; Yamazaki K; Naik H; Pienta KJ Anticancer Res; 1996; 16(2):815-20. PubMed ID: 8687134 [TBL] [Abstract][Full Text] [Related]
27. Rat prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells. Haq M; Goltzman D; Tremblay G; Brodt P Cancer Res; 1992 Sep; 52(17):4613-9. PubMed ID: 1511429 [TBL] [Abstract][Full Text] [Related]
29. Molecular mechanisms of (-)-gossypol-induced apoptosis in human prostate cancer cells. Huang YW; Wang LS; Chang HL; Ye W; Dowd MK; Wan PJ; Lin YC Anticancer Res; 2006; 26(3A):1925-33. PubMed ID: 16827126 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of prostate cancer growth by vinblastine and tamoxifen. Pienta KJ; Replogle T; Lehr JE Prostate; 1995 May; 26(5):270-4. PubMed ID: 7753712 [TBL] [Abstract][Full Text] [Related]
31. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102 [TBL] [Abstract][Full Text] [Related]
32. In vivo antitumor activity of bropirimine against PAIII and Dunning MAT-LyLu rodent prostate cancers. Sarosdy MF; Higdon AL; Demoor CA J Urol; 1996 Jun; 155(6):2085-9. PubMed ID: 8618341 [TBL] [Abstract][Full Text] [Related]
33. AT-101 (R-(-)-gossypol acetic acid) enhances the effectiveness of androgen deprivation therapy in the VCaP prostate cancer model. McGregor N; Patel L; Craig M; Weidner S; Wang S; Pienta KJ J Cell Biochem; 2010 Aug; 110(5):1187-94. PubMed ID: 20589722 [TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude mice. Stangelberger A; Schally AV; Varga JL; Zarandi M; Szepeshazi K; Armatis P; Halmos G Clin Cancer Res; 2005 Jan; 11(1):49-57. PubMed ID: 15671527 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of prostate cancer growth by 9-aminocamptothecin and estramustine. Naik H; Lehr JE; Pienta KJ Urology; 1996 Sep; 48(3):508-11. PubMed ID: 8804514 [TBL] [Abstract][Full Text] [Related]
36. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts. Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625 [TBL] [Abstract][Full Text] [Related]
37. Cytotoxicity of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone in androgen-dependent and -independent prostate cancer cell lines. Copeland RL; Das JR; Bakare O; Enwerem NM; Berhe S; Hillaire K; White D; Beyene D; Kassim OO; Kanaan YM Anticancer Res; 2007; 27(3B):1537-46. PubMed ID: 17595773 [TBL] [Abstract][Full Text] [Related]
38. Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells. Aalinkeel R; Nair MP; Sufrin G; Mahajan SD; Chadha KC; Chawda RP; Schwartz SA Cancer Res; 2004 Aug; 64(15):5311-21. PubMed ID: 15289337 [TBL] [Abstract][Full Text] [Related]
39. 9-Aminocamptothecin: a topoisomerase I inhibitor with preclinical activity in prostate cancer. de Souza PL; Cooper MR; Imondi AR; Myers CE Clin Cancer Res; 1997 Feb; 3(2):287-94. PubMed ID: 9815685 [TBL] [Abstract][Full Text] [Related]
40. Prostate carcinoma response to cytotoxic therapy: in vivo resistance. Teicher BA; Kakeji Y; Ara G; Herbst RS; Northey D In Vivo; 1997; 11(6):453-61. PubMed ID: 9509295 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]